Novo Nordisk says its obesity drug in higher dose shows 20.7% weight loss
Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...
The Economist2d
Is obesity a disease?
By coincidence (they started before GLP -1 drugs were approved for slimming), a group of 56 doctors have just answered that ...
New recommendations to measure obesity go beyond controversial BMI
Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...
The Advocate1h
Commission draws up new approach, definition of clinical obesity during Baton Rouge meeting
The Lancet, a global medical journal that works with academics to identify issues in public health, hosted a Commission on ...
We’re measuring obesity wrong — experts pinpoint 3 signs you may fit the bill regardless of your BMI
Our reframing acknowledges the nuanced reality of obesity and allows for personalized care,” said Dr. Francesco Rubino of ...
New guidelines encourage doctors to move beyond BMI for diagnosing obesity
A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...
Overhaul of obesity diagnosis will change its treatment
The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...
El País in English6h
What are the limits in the fight against obesity? Ozempic owner disappoints the market
Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...